Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), IL-21R inhibitors(Interleukin 21 Receptor inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | CN | 12 Dec 2023 |